Telomerase Proteins in Liver Cancer
Author Information
Author(s): Toshikuni N, Nouso K, Higashi T, Nakatsukasa H, Onishi T, Kaneyoshi T, Kobayashi Y, Kariyama K, Yamamoto K, Tsuji T
Primary Institution: Okayama University Medical School
Hypothesis
Are hTEP1 and hTERT useful markers for telomerase activation in human liver diseases?
Conclusion
The study found that hTERT is strongly expressed in most hepatocellular carcinomas, indicating its role in regulating telomerase activity in the liver.
Supporting Evidence
- hTEP1 was expressed in all samples examined.
- No correlation between hTEP1 expression and telomerase activity was observed.
- hTERT expression significantly correlated with telomerase activity.
- 100% positivity of hTERT for HCC and 30.4% for non-cancerous liver was observed.
- 74% of HCCs showed strong hTERT expression, while none of the non-cancerous liver tissues did.
Takeaway
Researchers looked at liver cancer samples to see if certain proteins are linked to cancer. They found one protein, hTERT, is really important for cancer but another one, hTEP1, isn't.
Methodology
mRNA levels of hTEP1 and hTERT were analyzed in liver samples using semiquantitative reverse transcription-polymerase chain reaction, and telomerase activity was assessed by a telomeric repeat amplification protocol assay.
Statistical Information
P-Value
P< 0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website